Interacting Drugs |
Lansoprazole, amoxicillin, and clarithromycin vs Lapatinib |
Security Level |
 |
Mechanism |
Lapatinib: CYP3A4 Inhibitors (Strong) may increase the serum concentration of Lapatinib. |
Management |
If an overlap in therapy cannot be avoided, consider reducing lapatinib dose to 500 mg/day during, and within 1 week of completing, treatment with the strong CYP3A4 inhibitor. |
Lansoprazole, amoxicillin, and clarithromycin vs Lapatinib
Post Review about Lansoprazole, amoxicillin, and clarithromycin vs Lapatinib Click here to cancel reply.
Other Interactions of Lapatinib
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.